ENCIT-01
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ENCIT-01, covering 2025-05-28 to 2025-05-28. Get the full timeline:
Most recent: Clinical Trial Update: Engineered Neuroblastoma Cellular Immunotherapy (ENCIT)-01 [Phase 1]